Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Syngene Internation
Join Channel
Consolidated Standalone

Syngene Internation.

₹878.8 0.8 | 0.1%

Market Cap ₹35375 Cr.

Stock P/E 71.8

P/B 8.3

Current Price ₹878.8

Book Value ₹ 105.5

Face Value 10

52W High ₹945.8

Dividend Yield 0.14%

52W Low ₹ 608

Edit Ratio

Syngene Internation. Research see more...

Stocx User

Syngene International Ltd

Overview Inc. Year: 1993Industry: Business Support

Syngene International Ltd is a contract research enterprise. The Company is engaged in providing agreement research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its offerings consist of discovery chemistry and biology offerings, toxicology, pharmaceutical development, technique improvement/manufacture of intermediates, active pharmaceutical ingredients and bio-therapeutics. Its services consists of integrated, discovery and development offerings for novel molecular entities (NMEs) across commercial sectors, such as pharmaceutical, biopharmaceutical and biotechnology, amongst others. It specializes in undertaking discovery (from hit to candidate selection), development (together with pre-scientific and clinical studies, analytical and bio-analytical evaluation, and stability studies) and manufacturing (scale-up, pre-clinical and manufacturing components). It serves customers ranging from multinational agencies to start-ups.

Read More..

Syngene Internation. Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Syngene Internation. Quarterly Results

#(Fig in Cr.) Mar 2017 Jun 2017 Sep 2017
Net Sales 291 291 335
Other Income 40 33 28
Total Income 331 324 364
Total Expenditure 207 211 234
Operating Profit 124 113 130
Interest 3 5 5
Depreciation 31 32 30
Exceptional Income / Expenses 0 0 0
Profit Before Tax 90 76 94
Provision for Tax 12 14 18
Profit After Tax 78 62 77
Adjustments -78 -62 -77
Profit After Adjustments 0 0 0
Adjusted Earnings Per Share 2 1.6 1.9

Syngene Internation. Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 700 860 1107 1201 1423 1826 2012 2179 2601 3194 3203 917
Other Income 8 12 6 94 136 76 96 83 108 73 88 101
Total Income 708 872 1113 1295 1559 1902 2108 2263 2710 3266 3291 1019
Total Expenditure 486 579 727 816 1033 1291 1410 1528 1864 2261 2324 652
Operating Profit 222 293 387 478 526 611 698 735 846 1005 967 367
Interest 0 8 8 18 23 32 35 28 24 45 30 13
Depreciation 66 81 97 114 131 164 219 275 310 359 369 93
Exceptional Income / Expenses 0 0 0 0 0 0 71 35 -31 0 -11 0
Profit Before Tax 156 204 281 347 372 414 516 467 482 601 557 260
Provision for Tax 22 29 40 59 67 84 104 64 88 128 91 44
Profit After Tax 134 175 241 287 305 331 412 404 394 473 467 217
Adjustments 0 0 0 0 0 0 0 0 0 0 0 -217
Profit After Adjustments 134 175 241 287 305 331 412 404 394 473 467 0
Adjusted Earnings Per Share 3.6 4.4 6 7.2 7.6 8.3 10.3 10.1 9.8 11.8 11.6 5.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 14% 12% 16%
Operating Profit CAGR -4% 10% 10% 16%
PAT CAGR -1% 5% 7% 13%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 21% 13% 21% NA%
ROE Average 12% 13% 15% 19%
ROCE Average 14% 14% 16% 18%

Syngene Internation. Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 659 845 1025 1413 1720 1967 2174 2818 3292 3619 4192
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 19 725 690 586 347 0 512 532 489 100
Other Non-Current Liabilities 69 83 -0 8 27 168 325 328 441 291 394
Total Current Liabilities 462 475 534 600 783 1129 1540 1130 1232 1157 1099
Total Liabilities 1191 1422 2284 2711 3116 3611 4039 4789 5496 5768 5784
Fixed Assets 394 503 580 810 1030 1337 1984 2163 2354 2212 2277
Other Non-Current Assets 163 332 369 377 366 511 444 824 938 672 1656
Total Current Assets 634 586 1335 1524 1719 1763 1611 1801 2204 2355 1852
Total Assets 1191 1422 2284 2711 3116 3611 4039 4789 5496 5768 5784

Syngene Internation. Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 12 92 116 387 235 252 164 192 319 259 72
Cash Flow from Operating Activities 300 19 308 398 446 630 677 698 582 838 913
Cash Flow from Investing Activities -374 12 -751 -469 -350 -647 -428 -628 -612 -688 -384
Cash Flow from Financing Activities 155 -10 716 -81 -79 -72 -226 58 -31 -340 -536
Net Cash Inflow / Outflow 81 20 273 -152 17 -89 24 128 -61 -190 -6
Closing Cash & Cash Equivalent 92 116 387 235 252 164 192 319 259 72 67

Syngene Internation. Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 3.61 4.39 6.02 7.18 7.63 8.27 10.29 10.09 9.83 11.78 11.6
CEPS(Rs) 5.38 6.44 8.45 10.04 10.91 12.37 15.77 16.96 17.55 20.73 20.78
DPS(Rs) 0 21 1 1 1 0.5 0 0 1 1.25 1.25
Book NAV/Share(Rs) 17.63 20.92 25.15 34.7 42.3 48.48 53.38 68.54 79.97 88.59 103.83
Core EBITDA Margin(%) 30.52 32.69 34.36 32.03 27.41 29.28 29.93 29.88 28.36 29.17 27.4
EBIT Margin(%) 22.32 24.58 26.14 30.31 27.74 24.46 27.35 22.72 19.44 20.21 18.3
Pre Tax Margin(%) 22.26 23.67 25.38 28.85 26.15 22.69 25.63 21.45 18.52 18.8 17.38
PAT Margin (%) 19.14 20.35 21.75 23.92 21.44 18.11 20.45 18.52 15.14 14.79 14.55
Cash Profit Margin (%) 28.52 29.82 30.54 33.44 30.67 27.11 31.35 31.12 27.04 26.03 26.05
ROA(%) 13.98 13.4 13 11.5 10.47 9.83 10.76 9.15 7.66 8.4 8.08
ROE(%) 22.83 23.55 26.19 24 19.81 18.21 20.2 16.56 13.24 13.99 12.07
ROCE(%) 23.33 23.31 19.85 17.6 16.7 16.94 19.57 15.35 13.19 15.61 13.76
Receivable days 44.59 58.19 60.19 58.34 59.7 60.53 66.84 73.07 68.93 56.66 51.89
Inventory Days 8.56 11.31 12.55 10.62 15.16 12.94 6.22 7.1 16.77 29.24 32.26
Payable days 0 -2583.35 -5956.14 0 -4135.31 2996.51 0 -3345.11 -4008.24 -2153.93 1658.62
PER(x) 0 0 31.91 36.36 38.6 35.56 23.48 53.84 60.75 50.45 60.47
Price/Book(x) 0 0 7.64 7.53 6.96 6.06 4.53 7.93 7.46 6.71 6.76
Dividend Yield(%) 0 0 0.26 0.19 0.17 0.09 0 0 0.17 0.21 0.18
EV/Net Sales(x) 0.13 0.28 7.1 8.93 8.15 6.64 5 10.03 9.3 7.49 8.69
EV/Core EBITDA(x) 0.4 0.81 20.32 22.42 22.04 19.85 14.42 29.77 28.6 23.81 28.78
Net Sales Growth(%) 27.18 22.93 28.74 8.48 18.5 28.28 10.2 8.33 19.36 22.76 0.3
EBIT Growth(%) 44.14 35.43 36.9 25.78 8.46 13.1 23.25 -10.03 2.16 27.74 -9.18
PAT Growth(%) 37.19 30.69 37.6 19.31 6.2 8.39 24.43 -1.9 -2.45 20.11 -1.37
EPS Growth(%) 37.63 21.64 36.98 19.31 6.2 8.39 24.43 -1.9 -2.65 19.93 -1.52
Debt/Equity(x) 0.24 0.19 0.89 0.58 0.47 0.41 0.32 0.28 0.25 0.16 0.03
Current Ratio(x) 1.37 1.23 2.5 2.54 2.19 1.56 1.05 1.59 1.79 2.04 1.69
Quick Ratio(x) 1.34 1.17 2.43 2.6 2.13 1.54 1.03 1.55 1.64 1.75 1.49
Interest Cover(x) 390.25 26.76 34.45 20.8 17.39 13.82 15.9 17.87 20.99 14.29 19.89
Total Debt/Mcap(x) 0 0 0.12 0.08 0.07 0.07 0.07 0.04 0.03 0.02 0.01

Syngene Internation. Shareholding Pattern

# Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Promoter 70.41 70.29 64.86 64.86 54.88 54.8 54.79 54.79 54.79 54.72
FII 13.67 14.12 16.77 16.85 23.28 23.19 23.55 21.2 20.92 20.63
DII 4.43 4.21 6.77 7.04 10.73 11.19 11.7 14.62 15.79 16.78
Public 11.49 11.38 11.6 11.25 11.1 10.82 9.95 9.38 8.49 7.86
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 13% over the last 3 years.
  • Debtor days have increased from -2153.93 to 1658.62days.
  • Stock is trading at 8.3 times its book value.
  • The company has delivered a poor profit growth of 7% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Syngene Internation. News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!